Načítá se...
Immune checkpoint-based therapy in myeloid malignancies: a promise yet to be fulfilled
INTRODUCTION: Immune system evasion is essential for tumor cell survival and is mediated by the immunosuppressive tumor microenvironment and the activation of inhibitory immune checkpoints. While immune checkpoint-based therapy yielded impressive results in several advanced solid malignancies such a...
Uloženo v:
| Vydáno v: | Expert Rev Anticancer Ther |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6527485/ https://ncbi.nlm.nih.gov/pubmed/30887841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737140.2019.1589374 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|